Search research articles
Contact Us
Filters
Showing results (21-30 of 71) with videos related to
Page
of 8
Sort By:
Frontiers in Oncology
|
July 19, 2021
New-Onset Severe Cytopenia After CAR-T Cell Therapy: Analysis of 76 Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Linqin Wang, Ruimin Hong, Linghui Zhou, et al.
Discover Oncology
|
May 20, 2026
Immune microenvironment and its influence on CAR-T treatment outcomes in B-NHL
Danyang Li, Zhonghua Fu, Rui Liu, et al.
NPJ Precision Oncology
|
April 10, 2026
CD22-targeted immunotherapy for B-cell acute lymphoblastic leukemia progressing following CD19-targeted immunotherapy
Fengmei Song, Junfang Yang, Mingming Zhang, et al.
Frontiers in Immunology
|
October 16, 2023
Demethylating agents in combination with CD7-targeted CAR-T for the successful treatment of a case with mixed-phenotype acute leukemia relapsed after allogeneic hematopoietic stem cell transplantation: A Case Report
Ying Han, Hao Yao, Guang-Cui He, et al.
Blood Science (Baltimore, Md.)
|
March 16, 2026
Zanubrutinib enhances CD19 CAR T killing of B-cell lymphoma by inhibiting BTK phosphorylation, regulating PI3K/AKT/mTOR pathway, and promoting autophagy
Hao Yao, Ling Qiu, Shi-Hui Ren, et al.
Frontiers in Immunology
|
May 28, 2024
Case report: Donor-derived CLL-1 chimeric antigen receptor T-cell therapy for relapsed/refractory acute myeloid leukemia bridging to allogeneic hematopoietic stem cell transplantation after remission
Xiaojuan Miao, Yanrong Shuai, Ying Han, et al.
Frontiers in Oncology
|
October 18, 2021
Corrigendum: Short-Interval Sequential CAR-T Cell Infusion May Enhance Prior CAR-T Cell Expansion to Augment Anti-Lymphoma Response in B-NHL
Yuan Meng, Biping Deng, Luan Rong, et al.
International Journal of Hematology
|
September 10, 2025
Sequential intrathoracic injection and intravenous infusion of BCMA CAR-T cells in a patient with relapsed/refractory primary plasma cell leukemia
Wei Han, Shuyang Wang, Mingming Zhang, et al.
Experimental Hematology & Oncology
|
March 5, 2024
Cytokine-based models for efficient differentiation between infection and cytokine release syndrome in patients with hematological malignancies
Linqin Wang, Yuqi Lv, Linghui Zhou, et al.
Frontiers in Oncology
|
November 18, 2021
Efficacy and Safety of Chimeric Antigen Receptor T Cells in Acute Lymphoblastic Leukemia With Post-Transplant Relapse
Lijuan Ding, Yiyun Wang, Ruimin Hong, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 71) with videos related to
Sort By:
Page
of 8
Frontiers in Oncology
|
July 19, 2021
New-Onset Severe Cytopenia After CAR-T Cell Therapy: Analysis of 76 Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Linqin Wang, Ruimin Hong, Linghui Zhou, et al.
Discover Oncology
|
May 20, 2026
Immune microenvironment and its influence on CAR-T treatment outcomes in B-NHL
Danyang Li, Zhonghua Fu, Rui Liu, et al.
NPJ Precision Oncology
|
April 10, 2026
CD22-targeted immunotherapy for B-cell acute lymphoblastic leukemia progressing following CD19-targeted immunotherapy
Fengmei Song, Junfang Yang, Mingming Zhang, et al.
Frontiers in Immunology
|
October 16, 2023
Demethylating agents in combination with CD7-targeted CAR-T for the successful treatment of a case with mixed-phenotype acute leukemia relapsed after allogeneic hematopoietic stem cell transplantation: A Case Report
Ying Han, Hao Yao, Guang-Cui He, et al.
Blood Science (Baltimore, Md.)
|
March 16, 2026
Zanubrutinib enhances CD19 CAR T killing of B-cell lymphoma by inhibiting BTK phosphorylation, regulating PI3K/AKT/mTOR pathway, and promoting autophagy
Hao Yao, Ling Qiu, Shi-Hui Ren, et al.
Frontiers in Immunology
|
May 28, 2024
Case report: Donor-derived CLL-1 chimeric antigen receptor T-cell therapy for relapsed/refractory acute myeloid leukemia bridging to allogeneic hematopoietic stem cell transplantation after remission
Xiaojuan Miao, Yanrong Shuai, Ying Han, et al.
Frontiers in Oncology
|
October 18, 2021
Corrigendum: Short-Interval Sequential CAR-T Cell Infusion May Enhance Prior CAR-T Cell Expansion to Augment Anti-Lymphoma Response in B-NHL
Yuan Meng, Biping Deng, Luan Rong, et al.
International Journal of Hematology
|
September 10, 2025
Sequential intrathoracic injection and intravenous infusion of BCMA CAR-T cells in a patient with relapsed/refractory primary plasma cell leukemia
Wei Han, Shuyang Wang, Mingming Zhang, et al.
Experimental Hematology & Oncology
|
March 5, 2024
Cytokine-based models for efficient differentiation between infection and cytokine release syndrome in patients with hematological malignancies
Linqin Wang, Yuqi Lv, Linghui Zhou, et al.
Frontiers in Oncology
|
November 18, 2021
Efficacy and Safety of Chimeric Antigen Receptor T Cells in Acute Lymphoblastic Leukemia With Post-Transplant Relapse
Lijuan Ding, Yiyun Wang, Ruimin Hong, et al.
Page
of 8